影响因素 |
| PFS单因素 |
|
| FPS多因素 |
|
| HR | 95% CI | P值 | HR | 95% CI | P值 |
性别 |
|
|
|
|
|
|
男 | 1 |
|
| 1 |
|
|
女 | 0.501 | 0.297~0.845 | 0.010 | 1.116 | 0.594~2.095 | 0.733 |
年龄(岁) |
|
|
|
|
|
|
<65 | 1 |
|
|
|
|
|
³65 | 1.446 | 0.890~2.347 | 0.136 |
|
|
|
肿瘤分期 |
|
|
|
|
|
|
III期 | 1 |
|
| 1 |
|
|
IV期 | 5.423 | 2.922~10.065 | 0.000 | 4.124 | 1.593~10.675 | 0.004 |
靶向药物 |
|
|
|
|
|
|
厄洛替尼 | 1 |
|
|
|
|
|
吉非替尼 | 1.007 | 0.620~1.636 | 0.977 |
|
|
|
血清白蛋白(g/L) |
|
|
|
|
|
|
<35 | 1 |
|
| 1 |
|
|
³35 | 0.407 | 0.239~0.693 | 0.001 | 3.567 | 0.549~23.185 | 0.183 |